TY - JOUR
T1 - US cost burden of ischemic stroke
T2 - A systematic literature review
AU - Demaerschalk, Bart M.
AU - Hwang, Ha Mill
AU - Leung, Grace
PY - 2010/7/1
Y1 - 2010/7/1
N2 - Background: Stroke is an expensive disease from a patient, caregiver, and societal perspective. In spite of the high cost burden, only limited numbers of recent studies have focused on stroke-related costs in the United States. Objective: To conduct a systematic literature review to determine current US costs of stroke and to assess if a gap in available information exists. Methods: A literature search was conducted using the PubMed/MEDLINE and Ovid/EMBASE databases, within the date range of January 1995 to July 2008. The search, screening, application of eligibility criteria, appraisal, data extraction, and synthesis were completed by one investigator and then independently confirmed by a second. Results: The literature review revealed that the majority of cost-related analyses focused on short-term in-hospital care and early critical care as the key drivers of acute ischemic stroke hospitalization costs. Moreover, long-term medical expenses resulting from nursing home and ambulatory care as well as indirect expenditure from lost earnings and informal care represent the most significant burden on lifetime costs of stroke. Conclusions: Further studies that focus on these long-term and indirect expenditures are essential to assess the impact of new treatments on total stroke costs. Overall, the high costs associated with stroke clearly indicate there is an imperative need for effective preventive therapy, early critical care, and rehabilitation, which in turn will reduce the national expenditure for stroke-related healthcare services and improve productivity.
AB - Background: Stroke is an expensive disease from a patient, caregiver, and societal perspective. In spite of the high cost burden, only limited numbers of recent studies have focused on stroke-related costs in the United States. Objective: To conduct a systematic literature review to determine current US costs of stroke and to assess if a gap in available information exists. Methods: A literature search was conducted using the PubMed/MEDLINE and Ovid/EMBASE databases, within the date range of January 1995 to July 2008. The search, screening, application of eligibility criteria, appraisal, data extraction, and synthesis were completed by one investigator and then independently confirmed by a second. Results: The literature review revealed that the majority of cost-related analyses focused on short-term in-hospital care and early critical care as the key drivers of acute ischemic stroke hospitalization costs. Moreover, long-term medical expenses resulting from nursing home and ambulatory care as well as indirect expenditure from lost earnings and informal care represent the most significant burden on lifetime costs of stroke. Conclusions: Further studies that focus on these long-term and indirect expenditures are essential to assess the impact of new treatments on total stroke costs. Overall, the high costs associated with stroke clearly indicate there is an imperative need for effective preventive therapy, early critical care, and rehabilitation, which in turn will reduce the national expenditure for stroke-related healthcare services and improve productivity.
UR - http://www.scopus.com/inward/record.url?scp=77955435925&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=77955435925&partnerID=8YFLogxK
M3 - Article
C2 - 20645668
AN - SCOPUS:77955435925
VL - 16
SP - 525
EP - 533
JO - American Journal of Managed Care
JF - American Journal of Managed Care
SN - 1088-0224
IS - 7
ER -